Chairman's message: Implicit bias and racism
This month’s issue takes on the pervasive problem of implicit bias and systemic racism in health care.
The double impact of the pandemic and protests have placed a spotlight on what could otherwise be ignored corners and crevices.
Starting on page 6, Editor-in-Chief Catherine Y. Spong, MD, tackles the topic of the inequities in women’s health research and has a call to action.
As is pointed out by Dr. Spong, correcting inequities demands a change of culture that requires committed and accountable leadership.
And so it goes that we must demand more from ourselves and organizations. Dr. Washington Clark Hill, who has been a practicing ob/gyn for 55 years, provides a wake-up call in his commentary on page 13.
He addresses the difference between equity and equality. Watch our interview with him that supplements his written piece. Sharing the cover story space with Dr. Hill are Vanessa Rogers, MD, and Shawna Nesbitt, MD, MS.
Dr. Rogers, a practicing ob/gyn, interviews Dr. Nesbitt, who is renowned for her work in diagnosing hypertensive disorders and also serves as Associate Dean of Student Diversity and Inclusion at the University of Texas Southwestern Medical Center in Dallas.
An accompanying interview with Drs. Rogers and Nesbitt appears online.
We want your thoughts on other groups that could be covered in similar ways. Please email Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com to share such ideas.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
